{
  "paper_metadata": {
    "pmid": "34089308",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.349G>A",
      "protein_notation": "p.Val117Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 343,
        "demographics": "patients with hypertrophic cardiomyopathy referred to tertiary centres",
        "phenotype": "cardiac amyloidosis (CA)"
      },
      "penetrance_data": {
        "total_carriers_observed": 343,
        "affected_count": 32,
        "unaffected_count": 311,
        "uncertain_count": null,
        "penetrance_percentage": 9.3,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "cardiac amyloidosis",
          "evidence_sentence": "recent studies showed that around 9.3% of 343 patients with HCM referred to tertiary centres have CA (5% ATTRwt, 3.5% ATTRv, and 0.9% AL)"
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with a higher risk of developing cardiac amyloidosis.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": "Prevalence in hypertrophic cardiomyopathy is 9.3%.",
      "evidence_level": "Strong evidence based on clinical studies.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is particularly common in African Americans and Afro-Caribbeans.",
      "key_quotes": [
        "The variant that is most commonly associated with ATTR-CA is ATTRV122I, which is the most common mutation identified in the USA, especially in the African Americans and Afro-Caribbeans."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.90C>T",
      "protein_notation": "p.Ala30Val",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 298,
        "demographics": "patients diagnosed with HCM in France",
        "phenotype": "ATTRv"
      },
      "penetrance_data": {
        "total_carriers_observed": 298,
        "affected_count": 15,
        "unaffected_count": 283,
        "uncertain_count": null,
        "penetrance_percentage": 5.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTRv",
          "evidence_sentence": "5% of 298 consecutive patients diagnosed with HCM in France had, in fact, ATTRv."
        }
      ],
      "functional_data": {
        "summary": "The variant is linked to a late-onset cardiac phenotype.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": "Prevalence in HCM is 5%.",
      "evidence_level": "Strong evidence based on clinical studies.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is associated with a better prognosis than ATTRV122I.",
      "key_quotes": [
        "In contrast, the most commonly spread mutation worldwide is ATTRV30M especially in endemic regions like Portugal, Scandinavia, and Japan."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}